Skip to main content
Premium Trial:

Request an Annual Quote

Biotage (Once Pyrosequencing) Expects Strong Q4 Revenue Growth

NEW YORK, Feb. 19 (GenomeWeb News) - Biotage, which changed its name from Pyrosequencing late last year, said it expects fourth-quarter 2003 sales to have increased and net loss to have narrowed.


Total receipts for the three-month period ended Dec. 31 jumped to SEK105 million ($14.5 million) from SEK34 million one year ago, the company said in an interim fourth-quarter earnings report.


The report, which was not comprehensive, also said net loss would decrease to SEK 31 million from SEK44 million in the same period one year ago.


The new company was created when Pyrosequencing bought US-based Biotage in October 2003 for around $30 million.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.